Submitted by Anonymous (not verified) on 28 November 2024 - 15:25
Opinion/decision on a Paediatric investigation plan (PIP): Breyanzi, Lisocabtagene maraleucel, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0448/2023
Source: